Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612, USA.
The Permanente Medical Group, Oakland, CA, USA.
Curr Osteoporos Rep. 2023 Oct;21(5):592-608. doi: 10.1007/s11914-023-00805-7. Epub 2023 Aug 5.
This review summarizes the current knowledge regarding osteoporosis and fracture among older US Asian adults.
Asian adults have lower (areal) bone density than non-Hispanic White adults and thus are more likely to be diagnosed and treated for osteoporosis, despite their lower risk of hip fracture. The latter may relate to favorable characteristics in hip geometry, volumetric bone density, and bone microarchitecture; lower risk of falls; and other clinical factors. The fracture risk calculator FRAX accounts for the lower risk of hip fracture among US Asian adults. However, data on major osteoporotic fracture risk remain limited. Fracture rates also vary by Asian subgroup, which may have implications for fracture risk assessment. Furthermore, among women receiving bisphosphonate drugs, Asian race is a risk factor for atypical femur fracture, an uncommon complication associated with treatment duration. Recent clinical trial efficacy data pertaining to lower bisphosphonate doses and longer dosing intervals may be relevant for Asian adults. More research is needed to inform osteoporosis care of US Asian adults, including risk-benefit considerations and the optimal duration of bisphosphonate treatment. Greater evidence-based guidance for primary fracture prevention among US Asian adults will ensure health equity in the prevention of osteoporotic fractures.
本文总结了目前关于美国亚裔老年人骨质疏松症和骨折的相关知识。
尽管美国亚裔髋部骨折风险较低,但他们的骨密度(面积)比非西班牙裔白人成年人低,因此更有可能被诊断和治疗骨质疏松症。后者可能与髋部几何形状、体积骨密度和骨微观结构的有利特征、较低的跌倒风险以及其他临床因素有关。骨折风险计算器 FRAX 考虑到了美国亚裔髋部骨折风险较低的因素。然而,关于主要骨质疏松性骨折风险的数据仍然有限。骨折率也因亚裔亚组而异,这可能对骨折风险评估有影响。此外,在接受双磷酸盐药物治疗的女性中,亚洲种族是股骨非典型性骨折的一个风险因素,这是一种与治疗时间有关的罕见并发症。最近与较低双磷酸盐剂量和更长给药间隔相关的临床试验疗效数据可能与亚洲成年人有关。需要更多的研究来为美国亚裔成年人提供骨质疏松症护理,包括风险效益考虑和双磷酸盐治疗的最佳持续时间。为美国亚裔成年人提供更多基于证据的一级骨折预防指南,将确保在预防骨质疏松性骨折方面实现健康公平。